Thomas E. Zapadka

Aryl Hydrocarbon Receptor Agonist VAF347 Impedes Retinal Pathogenesis in Diabetic Mice

Julia C. Batoki, S. Howell, Patricia R. Taylor, 2021, International journal of molecular sciences.

Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability.

T. Kern, S. Sigurdardottir, Haitao Liu, 2019, Cellular immunology.

RORγt Inhibitor-SR1001 Halts Retinal Inflammation, Capillary Degeneration, and the Progression of Diabetic Retinopathy

S. Howell, Patricia R. Taylor, Jie-long Tang, 2020, International journal of molecular sciences.

Diabetes induces IL-17A-Act1-FADD-dependent retinal endothelial cell death and capillary degeneration.

T. Kern, Dawn G. Smith, S. Sigurdardottir, 2019, Journal of diabetes and its complications.

Retinal Inflammation, Oxidative Stress, and Vascular Impairment Is Ablated in Diabetic Mice Receiving XMD8-92 Treatment

Julia C. Batoki, S. Howell, Patricia R. Taylor, 2021, Frontiers in Pharmacology.

Inhibition of CD40-TRAF6-dependent inflammatory activity halts the onset of diabetic retinopathy in streptozotocin-diabetic mice

S. Howell, Patricia R. Taylor, CHIEH-ALLEN Lee, 2022, Nutrition & Diabetes.

IL-17A Enhances Retinal Neovascularization

S. Howell, Patricia R. Taylor, CHIEH-ALLEN Lee, 2023, International journal of molecular sciences.